↓ Skip to main content

Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials

Overview of attention for article published in Annals of the Rheumatic Diseases, January 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#39 of 7,457)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
40 news outlets
blogs
1 blog
twitter
3 X users

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
32 Mendeley